Home

крокодил банка местен nanexa spotlight радар максима скърцане

Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter

Nanexa AB - Home
Nanexa AB - Home

133/20 – Nanexa AB will be delisted after close of the market on May 28, 2020
133/20 – Nanexa AB will be delisted after close of the market on May 28, 2020

Nanexa AB - NEX-18
Nanexa AB - NEX-18

Nanexa AB - NEX-18
Nanexa AB - NEX-18

Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter

Nanexa AB - NEX-18
Nanexa AB - NEX-18

Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter

Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter

Annual report 2021
Annual report 2021

Lindahl biträder Nanexa i kapitalanskaffning
Lindahl biträder Nanexa i kapitalanskaffning

Nanexa
Nanexa

INTERIM REPORT January – June 2022
INTERIM REPORT January – June 2022

Untitled
Untitled

Nanexa
Nanexa

Nanexa: närmar sig kliniska prövningar för unik drug delivery-metod | Placera
Nanexa: närmar sig kliniska prövningar för unik drug delivery-metod | Placera

Nanexa
Nanexa

Nanexa
Nanexa

Nanexas företrädesemission fulltecknad - IPO.se
Nanexas företrädesemission fulltecknad - IPO.se

76/20 - Information regarding Nanexa AB's subscription options
76/20 - Information regarding Nanexa AB's subscription options

Informationsbroschyr
Informationsbroschyr

KALLELSE TILL ÅRSSTÄMMA I NANEXA AB (PUBL) Aktieägarna i Nanexa AB (publ), 556833-0285 (”Bolaget”), kallas härmed till
KALLELSE TILL ÅRSSTÄMMA I NANEXA AB (PUBL) Aktieägarna i Nanexa AB (publ), 556833-0285 (”Bolaget”), kallas härmed till

23/19 – Last day of trading in Nanexa AB subscription option
23/19 – Last day of trading in Nanexa AB subscription option

ABG Sundal Collier - Nanexa - Nanexa brings US patent suit against VitriVax
ABG Sundal Collier - Nanexa - Nanexa brings US patent suit against VitriVax

ABG Sundal Collier - Nanexa - Adding another layer to drug development
ABG Sundal Collier - Nanexa - Adding another layer to drug development